Goldman Sachs’s Chimerix, Inc. CMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,402,845
| Closed | -$11.9M | – | 6570 |
|
|
2025
Q1 | $11.9M | Buy |
1,402,845
+905,655
| +182% | +$5M | ﹤0.01% | 2526 |
|
|
2024
Q4 | $1.73M | Buy |
497,190
+4,759
| +1% | +$6.71K | ﹤0.01% | 4407 |
|
|
2024
Q3 | $458K | Sell |
492,431
-203,176
| -29% | -$181K | ﹤0.01% | 5096 |
|
|
2024
Q2 | $609K | Sell |
695,607
-463,874
| -40% | -$440K | ﹤0.01% | 4720 |
|
|
2024
Q1 | $1.23M | Sell |
1,159,481
-20,052
| -2% | -$20.9K | ﹤0.01% | 4211 |
|
|
2023
Q4 | $1.14M | Buy |
1,179,533
+14,389
| +1% | +$13.9K | ﹤0.01% | 4316 |
|
|
2023
Q3 | $1.12M | Sell |
1,165,144
-266,261
| -19% | -$290K | ﹤0.01% | 4193 |
|
|
2023
Q2 | $1.73M | Buy |
1,431,405
+175,080
| +14% | +$222K | ﹤0.01% | 3976 |
|
|
2023
Q1 | $1.58M | Buy |
1,256,325
+8,211
| +0.7% | +$13.4K | ﹤0.01% | 4041 |
|
|
2022
Q4 | $2.32M | Buy |
1,248,114
+216,671
| +21% | +$424K | ﹤0.01% | 3831 |
|
|
2022
Q3 | $1.99M | Buy |
1,031,443
+665,156
| +182% | +$1.49M | ﹤0.01% | 3978 |
|
|
2022
Q2 | $762K | Sell |
366,287
-382,805
| -51% | -$1.23M | ﹤0.01% | 4806 |
|
|
2022
Q1 | $3.43M | Buy |
749,092
+232,839
| +45% | +$1.3M | ﹤0.01% | 3717 |
|
|
2021
Q4 | $3.32M | Buy |
516,253
+223,230
| +76% | +$1.34M | ﹤0.01% | 3795 |
|
|
2021
Q3 | $1.81M | Buy |
293,023
+211,679
| +260% | +$1.46M | ﹤0.01% | 4291 |
|
|
2021
Q2 | $651K | Sell |
81,344
-581,493
| -88% | -$4.84M | ﹤0.01% | 5058 |
|
|
2021
Q1 | $6.39M | Buy |
662,837
+602,890
| +1,006% | +$5.53M | ﹤0.01% | 2919 |
|
|
2020
Q4 | $289K | Buy |
59,947
+15,184
| +34% | +$55K | ﹤0.01% | 4909 |
|
|
2020
Q3 | $112K | Sell |
44,763
-69,076
| -61% | -$204K | ﹤0.01% | 5065 |
|
|
2020
Q2 | $353K | Sell |
113,839
-140,770
| -55% | -$364K | ﹤0.01% | 4552 |
|
|
2020
Q1 | $367K | Sell |
254,609
-24,077
| -9% | -$42.1K | ﹤0.01% | 4386 |
|
|
2019
Q4 | $565K | Sell |
278,686
-33,358
| -11% | -$61.5K | ﹤0.01% | 4433 |
|
|
2019
Q3 | $733K | Buy |
312,044
+7,332
| +2% | +$21.2K | ﹤0.01% | 4230 |
|
|
2019
Q2 | $1.32M | Buy |
304,712
+204,582
| +204% | +$629K | ﹤0.01% | 3808 |
|
|
2019
Q1 | $210K | Buy |
100,130
+2,848
| +3% | +$6.49K | ﹤0.01% | 4776 |
|
|
2018
Q4 | $250K | Sell |
97,282
-38,814
| -29% | -$130K | ﹤0.01% | 4726 |
|
|
2018
Q3 | $529K | Buy |
136,096
+42,907
| +46% | +$183K | ﹤0.01% | 4395 |
|
|
2018
Q2 | $443K | Buy |
93,189
+23,796
| +34% | +$114K | ﹤0.01% | 4584 |
|
|
2018
Q1 | $361K | Buy |
69,393
+39,874
| +135% | +$202K | ﹤0.01% | 4684 |
|
|
2017
Q4 | $137K | Buy |
+29,519
| New | +$140K | ﹤0.01% | 5607 |
|
|
2017
Q2 | – | Sell |
-29,788
| Closed | -$190K | – | 7022 |
|
|
2017
Q1 | $190K | Sell |
29,788
-3,273
| -10% | -$18.6K | ﹤0.01% | 5759 |
|
|
2016
Q4 | $152K | Sell |
33,061
-385,994
| -92% | -$1.82M | ﹤0.01% | 5943 |
|
|
2016
Q3 | $2.32M | Buy |
419,055
+350,957
| +515% | +$1.61M | ﹤0.01% | 3696 |
|
|
2016
Q2 | $268K | Sell |
68,098
-106
| -0.2% | -$524 | ﹤0.01% | 5440 |
|
|
2016
Q1 | $349K | Buy |
68,204
+57,896
| +562% | +$378K | ﹤0.01% | 5114 |
|
|
2015
Q4 | $92K | Buy |
10,308
+5,269
| +105% | +$190K | ﹤0.01% | 6224 |
|
|
2015
Q3 | $192K | Sell |
5,039
-27,223
| -84% | -$1.34M | ﹤0.01% | 6047 |
|
|
2015
Q2 | $1.49M | Buy |
32,262
+24,807
| +333% | +$994K | ﹤0.01% | 4149 |
|
|
2015
Q1 | $281K | Sell |
7,455
-12,934
| -63% | -$513K | ﹤0.01% | 5711 |
|
|
2014
Q4 | $821K | Buy |
20,389
+10,293
| +102% | +$349K | ﹤0.01% | 4797 |
|
|
2014
Q3 | $279K | Buy |
+10,096
| New | +$245K | ﹤0.01% | 5827 |
|
|
2014
Q2 | – | Sell |
-15,580
| Closed | -$356K | – | 7170 |
|
|
2014
Q1 | $356K | Sell |
15,580
-27,435
| -64% | -$554K | ﹤0.01% | 5589 |
|
|
2013
Q4 | $650K | Buy |
+43,015
| New | +$686K | ﹤0.01% | 5099 |
|
Other funds holding CMRX
Goldman Sachs's CMRX Position: Q2 2025 in Review
Goldman Sachs sold out of Chimerix, Inc. (CMRX) in Q2 2025, closing a stake of 1,402,845 shares — an estimated $11.9M sold.
Goldman Sachs first reported a position in CMRX in Q4 2013 and held it in 43 quarters. The position peaked at $11.9M in Q1 2025. 1 fund tracked by Wall St. Rank holds CMRX as of Q2 2025.
- Goldman Sachs reported no remaining Chimerix, Inc. position as of Q2 2025 after selling out during the quarter.
- Goldman Sachs sold 1,402,845 Chimerix, Inc. shares in Q2 2025, an estimated $11.9M.
- Goldman Sachs first reported a position in Chimerix, Inc. in Q4 2013 and held it in 43 quarters.
- Goldman Sachs's Chimerix, Inc. position peaked at $11.9M in Q1 2025.
- 1 fund tracked by Wall St. Rank held Chimerix, Inc. as of Q2 2025.
Based on Goldman Sachs's 13F filing for Q2 2025, filed 14 Aug 2025.